{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:01:58Z","timestamp":1787828518232,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bioorg.2023.106925","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T02:50:22Z","timestamp":1697597422000},"page":"106925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Jing-Yang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Long","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Can","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong-Lu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Heng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Gen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106925_b0005","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"10290","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2023.106925_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bioorg.2023.106925_b0015","first-page":"e200194","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"256","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bioorg.2023.106925_b0020","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/jcb.30247","article-title":"Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD\/MAFLD). Pathophysiology of NASH in endocrine diseases","volume":"123","author":"Flessa","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2023.106925_b0025","first-page":"e220194","article-title":"Treating inflammation to combat non-alcoholic fatty liver disease","volume":"256","author":"Wiering","year":"2022","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bioorg.2023.106925_b0030","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2023.106925_b0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","article-title":"The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease","volume":"20","author":"Sheng","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bioorg.2023.106925_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111972","article-title":"Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: bioactivities, structure-activity relationships and preliminary molecular mechanisms","volume":"188","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106925_b0045","article-title":"Discovery and development of tricyclic matrinic derivatives as anti-diabetic candidates by AMPK\u03b1 activation","volume":"34","author":"Li","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106925_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112315","article-title":"Structure-activity relationship and hypoglycemic activity of tricyclic matrines with advantage of treating diabetic nephropathy","volume":"201","author":"Tang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106925_b0055","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2023.106925_b0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/biom12040580","article-title":"Effects of glucose metabolism, lipid metabolism, and glutamine metabolism on tumor microenvironment and clinical implications","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2023.106925_b0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13287-018-1126-4","article-title":"An integrated characterization of contractile, electrophysiological, and structural cardiotoxicity of Sophora tonkinensis Gapnep. in human pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Wang","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bioorg.2023.106925_b0070","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.apsb.2022.03.001","article-title":"Mitochondria targeting drugs for neurodegenerative diseases-design, mechanism and application","volume":"12","author":"Xu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2023.106925_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cancers12010004","article-title":"Recent progress in mitochondria-targeted drug and drug-free agents for cancer therapy","volume":"12","author":"Jeena","year":"2019","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.bioorg.2023.106925_b0080","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41598-021-83688-x","article-title":"Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase II\u03b2 inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity","volume":"11","author":"Bavlovi\u010d Pisk\u00e1\u010dkov\u00e1","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106925_b0085","first-page":"386","article-title":"The preparation of 3-substituted-1,5-dibromopentanes as precursors to heteracyclohexanes, Beilstein","volume":"7","author":"Ringstrand","year":"2011","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106925_b0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10863-017-9725-9","article-title":"Triacsin C reduces lipid droplet formation and induces mitochondrial biogenesis in primary rat hepatocytes","volume":"49","author":"Dechandt","year":"2017","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bioorg.2023.106925_b0095","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/hep.32577","article-title":"Hepatocellular cystathionine \u03b3 lyase\/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor","volume":"76","author":"Xu","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.bioorg.2023.106925_b0100","doi-asserted-by":"crossref","first-page":"28263","DOI":"10.1073\/pnas.2000466117","article-title":"Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP\/NF-\u03baB\/NLRP3 inflammasome circuit","volume":"117","author":"Flores-Costa","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2023.106925_b0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2023.106925_b0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","article-title":"Regulation of energy metabolism by long-chain fatty acids","volume":"53","author":"Nakamura","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bioorg.2023.106925_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109212","article-title":"High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity","volume":"35","author":"Mana","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2023.106925_b0120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1248\/bpb.b21-00232","article-title":"Structural basis for anti-non-alcoholic fatty liver disease and diabetic dyslipidemia drug saroglitazar as a PPAR \u03b1\/\u03b3 dual agonist","volume":"44","author":"Honda","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2023.106925_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113083","article-title":"Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6\/STAT3 signaling pathway","volume":"150","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823005862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:19Z","timestamp":1758617179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823005862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"alternative-id":["S0045206823005862"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106925","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106925"}}